NUMANS Sets 30 April 2026 Board Meeting to Approve FY 2025 Results; Trading Remains Suspended
Bulletin Express
Apr 20
Numans Health Food Holdings Company Limited (NUMANS) has scheduled a board meeting for 30 April 2026 to review and approve its consolidated financial results for the year ended 31 December 2025, as well as to consider a possible final dividend.
Trading in NUMANS shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY 2025 results are released. The suspension follows the company’s 31 March 2026 disclosure regarding the delay in publishing its annual results.
The current board comprises Chairman Wang Ping and Executive Director Cui Juan, Non-Executive Director Chan Hok Leung, and Independent Non-Executive Directors Yim Wing Yee, Lau Kwok Fai Patrick, and Yu Tsz Ngo.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.